Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
J Thromb Haemost. 2013 Mar;11(3):512-20. doi: 10.1111/jth.12130.
Type 3 von Willebrand disease (VWD) is the most severe form of the disease and is classically inherited in an autosomal recessive fashion.
The aim of the current study was to investigate the molecular pathogenesis of a Canadian cohort of type 3 VWD patients.
Thirty-four families comprised of 100 individuals were investigated. Phenotypic data, including bleeding scores (BS), von Willebrand factor (VWF) laboratory values and anti-VWF inhibitor status were included as well as sequence analysis.
We identified 31 different mutations (20 novel): 8 frameshift, 5 splice site, 9 nonsense, 1 gene conversion, 6 missense and 2 partial gene deletion mutations. The majority of mutations identified were in the propeptide (42%); index cases (IC) with these mutations exhibited more severe bleeding (BS = 22) than those with mutations elsewhere in VWF (BS = 13). Sixty-two out of 68 (91%) mutant alleles were identified. Twenty-nine IC (85%) had a VWF null genotype identified; 17 homozygous, 12 compound heterozygous. In five IC (15%), two mutant VWF alleles were not identified to explain the type 3 VWD phenotype. In four ICs only one mutant VWF allele was identified and in one IC no mutant VWF alleles were identified.
We have investigated the molecular pathogenesis of a Canadian cohort of type 3 VWD patients. Obligate carriers are not phenotypically silent in the Canadian population; 48% have been diagnosed with type 1 VWD. In approximately 50% of families in this study the inheritance pattern for type 3 VWD is co-dominant and not recessive.
3 型血管性血友病(VWD)是该病最严重的形式,经典地以常染色体隐性遗传方式遗传。
本研究旨在研究加拿大 3 型 VWD 患者队列的分子发病机制。
研究了由 100 人组成的 34 个家族。包括表型数据(包括出血评分[BS]、血管性血友病因子[VWF]实验室值和抗 VWF 抑制剂状态)、序列分析。
我们鉴定了 31 种不同的突变(20 种新突变):8 种移码突变、5 种剪接位点突变、9 种无义突变、1 种基因转换、6 种错义突变和 2 种部分基因缺失突变。鉴定出的大多数突变发生在前肽(42%);具有这些突变的索引病例(IC)比 VWF 其他部位突变的患者(BS=13)表现出更严重的出血(BS=22)。68 个突变等位基因中有 62 个(91%)被鉴定出来。29 个 IC(85%)鉴定出 VWF 无效基因型;17 个纯合子,12 个复合杂合子。在 5 个 IC(15%)中,有两个突变的 VWF 等位基因无法解释 3 型 VWD 表型。在 4 个 IC 中,只鉴定出一个突变的 VWF 等位基因,而在 1 个 IC 中未鉴定出突变的 VWF 等位基因。
我们研究了加拿大 3 型 VWD 患者队列的分子发病机制。在加拿大人群中,强制性携带者并非表型沉默;48%的患者被诊断为 1 型 VWD。在本研究中,大约 50%的家族中,3 型 VWD 的遗传模式是共显性的,而不是隐性的。